Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Lymphoma Research Foundation Annual Gala Raises More Than $2 Million to Advance Research and Patient Support Services
  • USA - English


News provided by

Allison + Partners

Sep 28, 2018, 21:00 ET

Share this article

Share toX

Share this article

Share toX

Michael Werner (LRF Board of Directors, Chair), Meghan Gutierrez (LRF, CEO), Laura & Lloyd Blankfein (Goldman Sachs, CEO), Clay Siegall (Seattle Genetics, CEO), John Leonard, MD (Weill Cornell)
Michael Werner (LRF Board of Directors, Chair), Meghan Gutierrez (LRF, CEO), Laura & Lloyd Blankfein (Goldman Sachs, CEO), Clay Siegall (Seattle Genetics, CEO), John Leonard, MD (Weill Cornell)

NEW YORK (PRWEB) September 28, 2018 -- The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and support services – held its Annual Gala at the historic Plaza Hotel in New York City on Thursday, September 27, 2018. The record-setting Gala raised $2.3 million in support of LRF’s mission to eradicate lymphoma and serve all those impacted by this blood cancer and served as an ideal culmination to Blood Cancer Awareness Month.

The evening’s program honored those whose contributions to LRF and the broader lymphoma community have made a significant impact. The Distinguished Service Award was presented to Dr. John Leonard, the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Executive Vice Chair of the Weill Department of Medicine and Associate Dean for Clinical Research at Weill Cornell Medicine; Past Chair (2012-2015) and current member of LRF’s Scientific Advisory Board; and a current member of LRF’s Board of Directors, for his longstanding support of the Lymphoma Research Foundation, his dedication to lymphoma patients and their loved ones, and his achievements in lymphoma research and clinical care. The Lymphoma Research Foundation honored Seattle Genetics with the Corporate Leadership Award in recognition of their unique commitment to adolescent and young adult patients and their continued dedication to advancing therapies for lymphoma patients.

“We are honored to partner with and humbled to be recognized by the Lymphoma Research Foundation,” said Clay Siegall, Ph.D., President and Chief Executive Officer of Seattle Genetics. “Seattle Genetics’ mission and passion to help cancer patients aligns with LRF’s commitment to improve the lives of all those impacted by lymphoma. We look forward to our continued work together and to the day that we can eradicate this blood cancer.”

This year’s Raise it for LRF segment, presided over by Sotheby’s C. Hugh Hildesley, raised more than $500,000 in just a matter of minutes. During this unique and exciting portion of the evening, individual attendees pledged from $500 to $100,000 to support LRF’s mission.

“We are incredibly grateful to all those who helped make this year’s Gala the most successful in the event’s history,” said Meghan Gutierrez, LRF Chief Executive Officer. "Thanks to the generosity of all those involved in this event, the Lymphoma Research Foundation can continue to expand its efforts to invest in promising lymphoma research and improve patient care through education and support services.”

The Annual Gala was chaired by Laura and Lloyd Blankfein. The Connors Family; Friedman Family Foundation; Goldman Sachs Gives, at the request of R. Martin Chavez; and Jerry Speyer & Katherine Farley served as the event’s Presenting Sponsors. Guests and honorees at this year’s Gala were encouraged to wear red in recognition of Blood Cancer Awareness Month, held each year during the month of September to raise funds and awareness for blood cancer. Culminating with the 2018 Annual Gala, this year’s Blood Cancer Awareness Month boasted approximately 100 buildings that lit red as a part of LRF’s signature Light it Red for Lymphoma initiative.

For more information on the evening’s success and to support the Lymphoma Research Foundation’s mission, visit lymphoma.org/gala.

About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded more than $60 million in lymphoma-specific research.

For additional information on LRF’s research, education and services, visit lymphoma.org.

Clarissa Dickinson, Allison + Partners, 6464280619, [email protected]

Modal title

John Leonard, MD (Weill Cornell Medicine) and Lloyd Blankfein (Goldman Sachs, CEO)
John Leonard, MD (Weill Cornell Medicine) and Lloyd Blankfein (Goldman Sachs, CEO)
Clay Siegall (Seattle Genetics, CEO) and Meghan Gutierrez (Lymphoma Research Foundation, CEO)
Clay Siegall (Seattle Genetics, CEO) and Meghan Gutierrez (Lymphoma Research Foundation, CEO)
John Leonard, MD (Weill Cornell Medicine) and Lloyd Blankfein (Goldman Sachs, CEO) Clay Siegall (Seattle Genetics, CEO) and Meghan Gutierrez (Lymphoma Research Foundation, CEO)

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.